- D16.4 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D16.4 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D16.4 – other international versions of ICD-10 D16.4 may differ.
ICD-10-CM D16.4 is grouped within Diagnostic Related Group(s):
- 011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc
- 012 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with cc
- 013 Tracheostomy for face, mouth and neck diagnoses or laryngectomy without cc/mcc
- 564 Other musculoskeletal system and connective tissue diagnoses with mcc
- 565 Other musculoskeletal system and connective tissue diagnoses with cc
- 566 Other musculoskeletal system and connective tissue diagnoses without cc/mcc
Applicable To
- Benign neoplasm of maxilla (superior)
- Benign neoplasm of orbital bone
- Keratocyst of maxilla
- Keratocystic odontogenic tumor of maxilla
Type 2 Excludes
- benign neoplasm of lower jaw bone (D16.5)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D16.4:
- upper jaw (bone) (maxilla) > calcifying odontogenic D16.5